65°F
weather icon Clear

Mid-November earliest Pfizer can seek virus vaccine OK, company says

NEW YORK — Pfizer Inc. cannot request emergency authorization of its COVID-19 vaccine before the third week of November — and that’s if everything goes well, the company’s CEO announced Friday.

Despite President Donald Trump’s repeated promises of a vaccine before Election Day, scientists have been cautioning that it’s unlikely data showing a leading shot actually works would come until November or December.

Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer CEO Albert Bourla has long said it’s possible testing might reveal by the end of October if his company’s vaccine actually protects against the coronavirus. But in Friday’s announcement, he made clear that effectiveness is only part of the equation.

The vaccine also must be proven safe. And to qualify for an “emergency use authorization,” any COVID-19 vaccine must track at least half the participants in large-scale studies for two months after their second dose, the time period in which side effects are likely to appear.

Bourla estimated Pfizer’s 44,000-person study will reach that milestone in the third week of November.

“We are operating at the speed of science,” he wrote in a letter posted to the company’s website.

The vaccine made by Pfizer and its German partner BioNTech are among several leading candidates in final testing.

Even if a vaccine emerges by year’s end, only limited doses will be available right away. The U.S. government is deciding who would be first in line, almost certainly health care workers, and estimates there may be enough for widespread vaccinations in the spring.

Don't miss the big stories. Like us on Facebook.
THE LATEST
Mike Pence’s top aide tests positive for coronavirus

A spokesman says Vice President Mike Pence will continue with his aggressive campaign schedule after his chief of staff, Marc Short, tested positive for the coronavirus Saturday.

Murkowski backs Barrett as confirmation vote looms

Supreme Court nominee Amy Coney Barrett won crucial backing Saturday when one of the last Republican holdouts against filling the seat during an election season announced support for President Donald Trump’s pick ahead of a confirmation vote expected Monday.

60,000 travelers arrive in Hawaii with pre-travel testing

Hawaii had about 60,000 travelers arrive in the islands in the first week of its pre-travel coronavirus testing program, a state effort to get the tourism-based economy moving again amid the pandemic.

FDA approves remdesivir to treat COVID-19

U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV.

Slain Utah student’s family receives $13.5M settlement

The parents of a University of Utah track athlete who was killed by her ex-boyfriend on campus two years ago reached a $13.5 million settlement Thursday with the university, which acknowledged that it didn’t handle the woman’s case properly.

Fatal shooting causes closure of Interstate 15 in California

A California Highway Patrol officer was wounded and a stolen-car suspect was killed in a gun battle at the end of a pursuit on a highway northeast of Los Angeles on Thursday, authorities said.

Google target in Justice Department antitrust lawsuit

The lawsuit marks the government’s most significant act to protect competition since its groundbreaking case against Microsoft more than 20 years ago.